000 | 01459 a2200433 4500 | ||
---|---|---|---|
005 | 20250516115526.0 | ||
264 | 0 | _c20140123 | |
008 | 201401s 0 0 eng d | ||
022 | _a1989-4600 | ||
024 | 7 |
_a10.1016/j.rpsm.2012.05.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPons i Villanueva, Alexandre | |
245 | 0 | 0 |
_aShould obesity be a limiting factor for clozapine treatment? _h[electronic resource] |
260 |
_bRevista de psiquiatria y salud mental _c |
||
300 |
_a75-9 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 |
_aClozapine _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aObesity _xcomplications |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSchizophrenia _xcomplications |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aWeight Gain _xdrug effects |
700 | 1 | _aRomero, Anna | |
700 | 1 | _aGoti, Javier | |
700 | 1 | _aFernandez-Egea, Emilio | |
700 | 1 | _aUndurraga, Juan | |
700 | 1 | _aCarne, Xavier | |
700 | 1 | _aBernardo, Miquel | |
773 | 0 |
_tRevista de psiquiatria y salud mental _gvol. 6 _gno. 2 _gp. 75-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.rpsm.2012.05.005 _zAvailable from publisher's website |
999 |
_c22200104 _d22200104 |